The ability of all four cardiac hormones to markedly decrease leptin levels was suggestive of a novel potential treatment target for hypertension in obesity, since these four cardiac hormones have demonstrated blood pressure-lowering properties (21–29). The gene discussed is LEP; the disease is obesity disorder.